ENTO
Price
$2.15
Change
+$0.24 (+12.57%)
Updated
Aug 28 closing price
Capitalization
3.42M
FBLG
Price
$0.62
Change
+$0.02 (+3.33%)
Updated
Aug 28 closing price
Capitalization
25.98M
81 days until earnings call
Interact to see
Advertisement

ENTO vs FBLG

Header iconENTO vs FBLG Comparison
Open Charts ENTO vs FBLGBanner chart's image
Entero Therapeutics
Price$2.15
Change+$0.24 (+12.57%)
Volume$274.36K
Capitalization3.42M
FibroBiologics
Price$0.62
Change+$0.02 (+3.33%)
Volume$343.72K
Capitalization25.98M
ENTO vs FBLG Comparison Chart in %
Loading...
ENTO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FBLG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ENTO vs. FBLG commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENTO is a Hold and FBLG is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (ENTO: $2.15 vs. FBLG: $0.62)
Brand notoriety: ENTO and FBLG are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ENTO: 11% vs. FBLG: 64%
Market capitalization -- ENTO: $3.42M vs. FBLG: $25.98M
ENTO [@Biotechnology] is valued at $3.42M. FBLG’s [@Biotechnology] market capitalization is $25.98M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENTO’s FA Score shows that 1 FA rating(s) are green whileFBLG’s FA Score has 0 green FA rating(s).

  • ENTO’s FA Score: 1 green, 4 red.
  • FBLG’s FA Score: 0 green, 5 red.
According to our system of comparison, ENTO is a better buy in the long-term than FBLG.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENTO’s TA Score shows that 5 TA indicator(s) are bullish while FBLG’s TA Score has 6 bullish TA indicator(s).

  • ENTO’s TA Score: 5 bullish, 4 bearish.
  • FBLG’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, FBLG is a better buy in the short-term than ENTO.

Price Growth

ENTO (@Biotechnology) experienced а +5.91% price change this week, while FBLG (@Biotechnology) price change was +5.31% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.14%. For the same industry, the average monthly price growth was +15.07%, and the average quarterly price growth was +29.15%.

Reported Earning Dates

FBLG is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (-1.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FBLG($26M) has a higher market cap than ENTO($3.42M). ENTO YTD gains are higher at: 15.220 vs. FBLG (-68.990). ENTO has higher annual earnings (EBITDA): -4.66M vs. FBLG (-12.55M). ENTO has more cash in the bank: 11.4M vs. FBLG (8.85M). ENTO has less debt than FBLG: ENTO (836K) vs FBLG (10.8M). ENTO (0) and FBLG (0) have equivalent revenues.
ENTOFBLGENTO / FBLG
Capitalization3.42M26M13%
EBITDA-4.66M-12.55M37%
Gain YTD15.220-68.990-22%
P/E Ratio0.03N/A-
Revenue00-
Total Cash11.4M8.85M129%
Total Debt836K10.8M8%
FUNDAMENTALS RATINGS
ENTO: Fundamental Ratings
ENTO
OUTLOOK RATING
1..100
38
VALUATION
overvalued / fair valued / undervalued
1..100
9
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ENTOFBLG
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
87%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
87%
MACD
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
74%
Advances
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 17 days ago
84%
Declines
ODDS (%)
Bearish Trend 15 days ago
90%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
78%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ENTO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FBLG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PAY38.720.52
+1.36%
Paymentus Holdings
ADSK288.492.54
+0.89%
Autodesk
PFLT10.180.03
+0.30%
PennantPark Floating Rate Capital Ltd
COHN12.340.01
+0.08%
Cohen & Company
MACI10.50N/A
N/A
Melar Acquisition Corp. I

ENTO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENTO has been loosely correlated with IVVD. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if ENTO jumps, then IVVD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENTO
1D Price
Change %
ENTO100%
+12.57%
IVVD - ENTO
60%
Loosely correlated
+13.66%
FBLG - ENTO
39%
Loosely correlated
+3.40%
RLMD - ENTO
35%
Loosely correlated
+15.76%
NEVPF - ENTO
31%
Poorly correlated
N/A
CABA - ENTO
31%
Poorly correlated
N/A
More

FBLG and

Correlation & Price change

A.I.dvisor indicates that over the last year, FBLG has been loosely correlated with TERN. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if FBLG jumps, then TERN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FBLG
1D Price
Change %
FBLG100%
+3.40%
TERN - FBLG
36%
Loosely correlated
+2.61%
VRDN - FBLG
34%
Loosely correlated
-0.65%
CCCC - FBLG
32%
Poorly correlated
-1.16%
IPSC - FBLG
32%
Poorly correlated
-2.91%
AURA - FBLG
32%
Poorly correlated
-0.16%
More